Pharmaceutical Supply Chain

CDC, FDA investigate harmful counterfeit Botox

April 19, 2024 - On April 15, 2024, the United States Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) launched an investigation into harmful reactions caused by counterfeit or mishandled botulinum toxin (Botox). According to a CDC outbreak investigation report, as of April 12, 2024, 19 reported illnesses caused by Botox...

Read More


More Articles

FDA requests $7.2 billion from Biden’s 2025 fiscal year budget

by Veronica Salib

On March 11, 2024, the United States FDA issued a press release announcing its request for $7.2 billion from the president’s fiscal year (FY) 2025 budget, increasing its FY 2023 request by 7.4%...

Revolutionizing Vaccine Storage and Distribution with Innovative Solutions

by Alivia Kaylor

The global COVID-19 pandemic has highlighted the critical role of vaccines in controlling the spread of infectious diseases. As the demand for vaccines continues to rise, developing innovative solutions for their storage and distribution...

Continuous Manufacturing Revolutionizes Pharmaceutical Production

by Alivia Kaylor

In the pharmaceutical sector, continuous manufacturing (CM) has emerged as a transformative technology with the potential to revolutionize the industry. As drugmakers seek to enhance efficiency, reduce costs, and ensure a resilient supply...

Amgen Opens Its Most Advanced Manufacturing Site in Central Ohio

by Alivia Kaylor

On February 26, 2024, Amgen announced it opened its latest manufacturing site in New Albany, Ohio, located in Central Ohio. The recently established facility stands out as a cornerstone in Amgen's...

Advancing Packaging Technologies for Climate-Adaptive Supply Chains

by Alivia Kaylor

The global climate crisis poses significant challenges to the biopharmaceutical industry, particularly regarding packaging and temperature control. The increasing unpredictability of weather patterns can lead to fluctuations in temperature...

Digitizing the Biopharmaceutical Supply Chain Improves Resilience

by Veronica Salib

Throughout the past few years, global, national, and industry-specific changes have posed challenges to the biopharmaceutical supply chain. Disruptions and shortages have caused industry leaders and regulatory organizations to look for...

A Pulse Check on Advancements in the Life Sciences, Pharma Industry

by Alivia Kaylor

In the life sciences and pharmaceutical industry, 2023 has seen remarkable advancements and breakthroughs that hold great promise for the future of healthcare. In a recent podcast episode of the Healthcare Strategies, Senior Editor Alivia...

Navigating the Complex Terrain of Influenza Vaccine Strain Selection

by Alivia Kaylor

In the battle against influenza, the annual selection of vaccine strains is a crucial step in ensuring the effectiveness of flu vaccines. The process involves an intricate dance of global surveillance, scientific analysis, and regulatory...

Biden Leverages DPA to Strengthen Pharmaceutical Supply Chain

by Veronica Salib

On Monday, November 27, 2023, the White House released a fact sheet from the Biden administration outlining plans to strengthen domestic supply chains, reduce consumer costs, and secure key supply...

Innovative Tech for Drug Manufacturing: Revolutionizing Pharma

by Alivia Kaylor

The pharmaceutical industry is no stranger to technological innovation. Over the years, it has seen numerous advancements in drug development, manufacturing processes, and quality control. However, in recent years, the pace of innovation...

CDC Urges Rationing of New Antibody Shot for Infant RSV Protection

by Alivia Kaylor

In response to the overwhelming demand for the newly approved antibody shot, Beyfortus, designed to safeguard newborns from respiratory syncytial virus (RSV), the Centers for Disease Control and...

Pediatric Amoxicillin Shortage Persists as Winter Approaches

by Veronica Salib

With October approaching, it has been nearly one year since the start of the amoxicillin shortage. According to the United States Food and Drug Administration (FDA), the deficiency was first identified...

7 Ways to Increase Pharmaceutical Sustainability

by Alivia Kaylor

The pharmaceutical sector is undeniably indispensable in the global landscape of essential medications. However, beneath the surface lies a harsh reality of environmental devastation and unsustainable practices. A 2019 Lancet report paints...

More Eyedrops Recalled Due to Bacterial, Fungal Contamination

by Veronica Salib

On August 22, 2023, the United States Food and Drug Administration (FDA) issued a warning to consumers on two methylsulfonylmethane (MSM) eyedrops, reporting bacterial and fungal contaminations as the...

Over 99% of US Hospital Pharmacists Reported Drug Shortages

by Veronica Salib

The American Society of Health-System Pharmacists (ASHP) recently published statistics on ongoing drug shortages in the United States. The organization’s survey of hospital pharmacists revealed...

ADHD Medication Shortages Prompt Response from the FDA and DEA

by Veronica Salib

On August 1, 2023, the United States Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) released a public statement updating Americans on the ongoing shortages of prescription...

Pfizer Plant Damage May Cause Pharmaceutical Supply Chain Shortages

by Veronica Salib

A Tornado in Rocky Mount, North Carolina, caused significant damage to a Pfizer manufacturing plant. Experts predict that medication and pharmaceutical supply chain shortages are imminent. The company...

Cipla Albuterol Sulfate Inhalation Aerosol Voluntarily Recalled

by Veronica Salib

On July 6, 2023, Cipla US recalled six batches of its albuterol sulfate inhalation aerosol, 90 mcg (200 MI). According to the release published by the FDA on July 7, 2023, the company cited a container...

Top Challenges Facing Biosimilar Adoption and Manufacturing

by Veronica Salib

Biosimilar adoption by the healthcare industry can incentivize pharmaceutical development and increase options for patients, payers, and providers by offering a less expensive alternative to biologic...

Recent Articles